Work

Engineering primary T cells with chimeric antigen receptors for rewired responses to soluble ligands

Year: 2020

Type: article

Source: Nature Protocols

DOI: 10.1038/s41596-020-0294-8

Authors: ZeNan L. Chang, Andrew J. Hou, Yvonne Y. Chen

Institutions: University of California, Los Angeles, Washington University in St. Louis, Parker Institute for Cancer Immunotherapy

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute, NIH Office of the Director, National Cancer Institute, National Institute of General Medical Sciences, National Center for Advancing Translational Sciences

Awards: G1071925744, G2130928551, Engineering robust adoptive T-cell cancer therapy by rewiring TGF-beta signaling, G5177302090, Biotechnology Training in Biomedical Sciences and Engineering, G5450609266, G766868593, Engineering of computational receptors and gene circuits for T-cell immunotherapy, G7809861506, UC BRAID Center for Accelerated Innovation, Cancer Center Support Grant, UCLA Clinical and Translational Science Institute

OpenAlex ID: W3007039663

FWCI: 1.354

Cites: 35

Cited by: 25

Related to: 10